Symptom Communication in Advanced Cancer
A Mixed-Methods Pilot Study of Symptom Communication in Advanced Cancer: Patterns and Associating Factors
1 other identifier
observational
52
1 country
1
Brief Summary
Background Improving patient-provider communication is a fundamental and cost-effective method to advance patient outcomes, including symptom management which is often the primary goal of care for patients with advanced cancer. Unfortunately, some studies revealed the poor quality of symptom communication among cancer patients and healthcare providers. While these evidences suggest important gaps in communication about symptoms with some of the most vulnerable patients, little is known about the patterns and associating factors of symptom communication. Purpose and Specific Aims The proposed 3-year pilot project aims to provide an enrich and systematic description of symptom communication by validating a newly developed typology of interaction patterns of symptom communication (TIPSC) between patients with advanced cancer, their caregivers, and healthcare providers and explore factors related to each interaction pattern. The specific aims are to: (1) validate TIPSC in Taiwanese advanced cancer population, (2) explore patients' /caregivers' experience and thoughts of symptom discussion in regard to their interaction patterns and symptom management, and (3) examine relationships between interaction patterns and (a) demographic factors, (b) symptom severity, (c) congruence in symptom assessment between patients/caregivers and providers, (d) patients'/caregivers' perceived ability to communicate with providers, and (e) patient/caregiver satisfaction. Sampling This pilot study plans to recruit about 50 patient/caregiver - oncologist dyads. The recruitment process contains three stages. First, medical oncologists who are currently in clinical practice at participating institutions and care for patients with solid tumors will be approached. Second, participating oncologists' patients will be recruited if they are: (1) currently a patient of a participating oncologist, (2) diagnosed with stage III or IV solid cancer, (3) aged 20 years or older, (4) able to tolerate an interview that will last approximately 30 minus, and (5) able to speak Chinese or Taiwanese. Finally, if applicable, adult caregivers who intent to join selected out-patient-department (OPD) visit with the patients will also be recruited. Research Design This is a mixed-methods study with a two-phase exploratory sequential design. The first phase is a qualitative descriptive study in which the investigators will record patient/caregiver-oncologist OPD visits and conduct patient/caregiver interviews to address aim 1 and 2. Discourse and conversation analysis will be used to analyze the recorded visits and content analysis will be used to analyze the interviews. The second phase is a correlational study in which the investigators use questionnaires to measure variables and examine their relationship with interaction patterns (aim 3). Descriptive statistics, binomial logistic regression, and linear regression will be used to analyze quantitative data. Expecting Results This is a pioneering study addressing the patterns and associating factors of symptom communication in Taiwanese patients with advanced cancer. The findings will systematically map out the patient/caregiver-provider symptom communication and identify relationships between communication patterns and meaningful indicators. This proposed study is a critical step to understand patient/caregiver-provider communication regarding symptoms in order to pinpoint symptom management and communication barriers and design proper interventions in Taiwan.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 9, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 2, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
September 2, 2020
CompletedFirst Submitted
Initial submission to the registry
September 27, 2022
CompletedFirst Posted
Study publicly available on registry
December 28, 2022
CompletedDecember 28, 2022
September 1, 2018
1.6 years
September 27, 2022
December 19, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Chinese Patients' Satisfaction Scale (C-PSS)
patient satisfaction
Once, immediately after outpatient visit
Secondary Outcomes (1)
European Organization for Research and Treatment of Cancer (EORCT-QLQ C30)
Once, immediately after outpatient visit
Eligibility Criteria
Advanced cancer patients
You may qualify if:
- Currently a patient of a participating physician
- Diagnosed with advanced solid cancer (TNM stage III or IV)
- Aged 20 years or older
- Able to tolerate an interview that will last approximately 30 minus
- Able to speak Chinese or Taiwanese.
You may not qualify if:
- Do not experience any symptoms
- Are hospitalized at recruitment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Taiwan University Hospital
Taipei, 10051, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 27, 2022
First Posted
December 28, 2022
Study Start
January 9, 2019
Primary Completion
September 2, 2020
Study Completion
September 2, 2020
Last Updated
December 28, 2022
Record last verified: 2018-09
Data Sharing
- IPD Sharing
- Will not share